Megan E. Klatt, PharmD


Optimizing Antibiotic Use by Limiting Total Antibiotic Exposure

Shorter durations of antibiotic therapy demonstrate similar efficacy and may improve safety compared with longer courses for certain infections.

Philip Giordano, MD


In These COVID 19 Times, Can We Reduce Hospitalizations Due to Skin Infections?

Shortages of health care workers and an increase in COVID-19 cases has put a severe strain on the health care system. Thus, the opportunity to reduce the hospitalizations for other conditions and expand outpatient treatment opportunities should be welcomed.

Laura Selby, DO


Reducing Peripheral Venous Catheter Infections

Lack of data may mean bloodstream infections caused by PVCs are an overlooked cause of morbidity in hospitalized patients.

Rebecca Fallis, MD


Final Diagnosis: Pott Puffy Tumor With Subdural Empyema

A rare case of Pott puffy tumor occurs in an atypical patient with no risk factors, likely due to untreated sinus infection.

Eli Goshorn, MD


The Underlying Threat of Multidrug-Resistant Pathogens in the COVID-19 Era

Over half of patients admitted with positive SARS-CoV-2 testing received antibiotics, but evidence of bacterial infection is uncovered in far fewer cases. We may already be seeing the effects of antibiotic overprescribing.

Esther O. Fasanmi, PharmD, BCIDP, BCPS, AAHIVP


Biden Administration Unveils HCV Initiative: A Significant Step Towards Public Health

The federal government is working to provide greater access to testing and treatment.

Jessica Foley, PharmD, BCIDP


Shifting to Shorter Courses of Antibiotic Therapy for Common Pediatric Infections

In the latest SIDP column, two clinicians provide information on recent studies and guidelines directed at antibiotic durations in this patient population.

Tim Smith


A Common Health Habit May Lower Rates of Pneumonia, ICU Mortality

The data from these meta-analyses highlight the value of developing systems to promote daily toothbrushing among those who have been hospitalized and, particularly, those on mechanical ventilation.

Jaclyn O’Connor, PharmD


Sticking It to COVID-19: The Expansion of the Pfizer-BioNTech Vaccine EUA

A review of the data and circumstances that led to authorization in children ages 5 to 11 years.

Matthew Girgis, PHARMD, BCIDP


So You Made the Decision to Implement Vancomycin AUC Dosing. Now What?

Since the vancomycin guideline update, institutional leaders have been faced with the challenge of implementing and monitoring AUC-guided dosing.

James Donovan, MD


Final Diagnosis: Donor-Derived Staphylococcus Iugdunensis Endocarditis of Transplanted Heart

"This case gives uncomfortable insight into a gap in early detection of infections in immunocompromised, high-risk patient populations. "

Abigail Brooks, MA


Achieving SVR Reduces Risk of Cardiovascular Events in Patients with HCV

Results highlight the benefit of achieving sustained virological response with DAAs for decreasing patients’ risk of carotid atherosclerosis and peripheral artery disease, especially among those with severe fibrosis.

Valencia Oglesby, DO


Preparing for the Next Long-acting Antiretrovirals

Clinicians can make room for infrequent treatment options as patients enjoy their daily lives.

Paul Feuerstadt, MD


Advice for Physicians to Manage C. Difficile Infection (CDI)

Experts share advice for physicians taking care of patients with C. difficile infection (CDI).

Anna Zhou, PharmD, BCIDP


COVID-19 Impact on Antimicrobial Stewardship: Consequences and Silver Linings

This crisis has united multidisciplinary groups and laid the foundation to better equip the health care workforce for future pandemics.

Lana Pine


Combination Hepatitis C Therapy Efficacious in Those With Previously Untreated Acute Infection

Treatment with glecaprevir/pibrentasvir (G/P) demonstrated a virologic response at post-treatment week 12, which was superior to the prior efficacy threshold.

Christopher M. Bland, PHARMD, FCCP, FIDSA, BCPS


Starting an Inpatient Penicillin Skin Testing Service in 2023

Patients with a penicillin allergy can be safely delabeled using minimal resources, opening up treatment options.

Alice Hemenway, PharmD, BCPS, BCIDP, MPH


The Role of Rifampin in Bone and Joint Infections

In the latest column from the Society of Infectious Diseases Pharmacists (SIDP), here is a discussion on the use of rifampin as an adjunctive antibiotic treatment for patients with diabetic foot osteomyelitis.

Lois Levine, MA


What You Need to Know About 3 Rare Infectious Eye Diseases

Eric D. Donnenfeld, MD, discusses 3 uncommon yet highly infectious eye diseases, emphasizing the importance of timely treatment and preventative measures.

Jelena Lewis, PharmD, BCACP


What’s New With Non–COVID-19 Vaccines

Although COVID-19 vaccination remains the primary focus for health care, other paramount vaccines need to be recognized. Here is a review.

Marian Freedman


Fluoroquinolone Safe for Treating Severe Refractory M Pneumoniae Pneumonia

Investigators asked the children’s parents about the history of musculoskeletal-related disease, observed the children’s gait, and performed physical examinations.

Matthew J. Grant, MD


Barriers to Health Care Transition in Adolescents and Young Adults With Early Acquired HIV Infection

Unique challenges can affect the success of the shift from pediatric to adult care settings.

Tavell Kindall, PhD, DNP, APRN, FNP


Multidisciplinary Perspectives on HIV Treatment

A multidisciplinary panel concludes a discussion on best practices for managing patients with HIV in various healthcare settings and overcoming social health disparities.

Tina Tan, MD


Practice Pearls for Treatment of Respiratory Infections

Tina Tan, MD; Wendy Wright, DNP, ANP-BC, FNP-BC, FAANP, FAAN, FNAP; Priya Nori, MD; Jacinda Abdul-Mutakabbir, PharmD; and Kevin Michael Reiter, MD, PA, provide key takeaways from the discussion on the treatment of respiratory viral infections.

Claudine El-Beyrouty, PharmD, BCPS


Examining RSV Vaccines for Seniors

Two RSV vaccines for seniors were FDA approved this year and here is an overview of the vaccines and the study data.

Meghan N. Jeffres, PharmD, BCIDP


Antimicrobial Stewardship: More Is Better

A robust stewardship program requires a comprehensive investment in technology and staff.

© 2024 MJH Life Sciences

All rights reserved.